Introduction
A large body of evidence has demonstrated a significant role played by the rennin-angiotensin system in the pathogenesis of numerous cardiovascular diseases, including hypertension, hypercholesterolemia, and diabetes (1) . The recently completed HOPE trial demonstrated a remarkable decrease in car-diovascular morbidity and mortality by angiotensin converting enzyme (ACE) inhibition in individuals at increased risk for cardiovascular events (2) . Angiotensin II (Ang II), the principle effector of the renin-angiotensin system, is known to be a potent vasoconstrictor by itself, and plays an essential role in the regulation of blood pressure. Furthermore, Ang II has been shown to exert other important effects in the vasculature (3) . Activation of the Ang II type 1 (AT1)-receptor by Ang II leads to a variety of intracellular signaling evens, ultimately causing endothelial dysfunction, proliferation of vascular smooth muscle cells, expression of pro-inflammatory genes, and reconstruction of extracellular matrix, which are known to cause vasoconstriction and atherosclerotic plaque formation and rupture (1) . Moreover, one of the important effects of Ang II is to promote oxidative stress by the enhancement of reactive oxygen species (ROS) such as superoxide through activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, a major source of the production of ROS in vascular cells (1) . The increased oxidative stress induced by Ang II contributes to vascular endothelial cell dysfunction, which has received a great deal of attention as a common feature in the development of atherosclerosis and associated complications (1) .
Lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (LOX-1), which is a type-II membrane protein that belongs to a family of C-type lectin-like molecules, was identified as a novel scavenger receptor for oxidized LDL (OxLDL) in vascular endothelial cells (4, 5) . It binds, internalizes, and degrades OxLDL but not native LDL or acetylated LDL. The expression of LOX-1 in endothelial cells is relatively lower in the basal condition, but it can be upregulated by OxLDL, Ang II, inflammatory cytokines, vasoconstrictive peptide, and shear stress in vitro; and in proatherogenic conditions in vivo, including hypertension, diabetes mellitus, and hyperlipidemia, as well as in atherosclerosis per se (6, 7) . Moreover, free radicals have also been shown to induce the expression of LOX-1 (7) . Recent studies have shown that the expression of LOX-1 is also upregulated in atherosclerotic tissues from rabbits and humans (8, 9) . Interestingly, this inducible nature of LOX-1 suggests that LOX-1 may play an active role in complex atherogenic processes, such as the induction of adhesion molecules, monocyte chemotactic protein-1, and growth factors, as well as in the further generation of superoxide (7) .
Dihydropyridine calcium channel blockers are known to exhibit vasoprotective effects in response to cardiovascular events. Furthermore, these agents reduce cardiovascular mortality in patients after myocardial infarction (10) . Amlodipine has been shown to limit the progression of arteriosclerosis and atherosclerosis in animals and humans (11) (12) (13) (14) . Although the mechanisms underlying the direct protective effects of calcium channel blockers are not fully understood, such vasoprotective effects as amelioration of endothelial dysfunction (15) and decreases in the proliferation of vascular smooth muscle cells (16) , oxidative stress (17) and inflammation (18, 19) , are at least partly independent of the blood pressure-lowering effects of these agents-in other words, they are independent of the effects of these agents via calcium channels. Several lines of evidence suggest that calcium channel blockers also possess antioxidant activity, primarily due to their chain-breaking antioxidative action, preservation of scavengers, and direct scavenging of peroxyl radical-mediated oxidation (20) .
To investigate the vasoprotective effects of calcium channel blockers such as amlodipine and manidipine, we analyzed the levels of ROS and the expression of molecules associated with oxidative stress and inflammation, including the expression of LOX-1, in Ang II-treated rat aortic endothelial cells.
Methods

Cell Culture
Rat aortic cells were isolated from male Wistar rats (Shimizu Laboratory Supply, Kyoto, Japan) weighing 250 g by a previously described primary explant technique (21) . All rats were cared for in accordance with the guidelines for animal experiments at Kyoto Pharmaceutical University. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 15% fetal bovine serum, endothelial cell growth supplement (100 μg/ml), and antibiotics (50 μg/ml ampicillin, 15 μg/ml gentamicin, 1 μg/ml minomycin, and 1 μg/ml amphotericin B). Rat tail collagen (type 1)-coated tissue culture dishes (35 mm; Biocoat Cell Ware; Becton Dickinson Labware, Two Oak Park, USA) were used for the endothelial cell culture, and cells from passage 3 were used for the experiments. After reaching 90% confluence, the endothelial cells were incubated in conditioned medium (DMEM containing 1.0% bovine serum albumin and antibiotics) for 24 h before the initiation of experiments in order to induce quiescence, and then the conditioned medium was exchanged for new medium at the start of the experiments.
Study Design
In preliminary studies, cells were incubated with Ang II (10 − 7 mol/l) for 1, 3, 6, or 24 h in order to determine the production of superoxide. The duration resulting in the maximal effect of Ang II was used in subsequent experiments. In parallel experiments, cells were pretreated with amlodipine (10 − 6 mol/l) or manidipine (10 − 6 mol/l) for 60 min before incubation with Ang II. Cells were washed three times with phosphate buffed saline (PBS), and were used for subsequent analysis. The concentration of Ang II was chosen on the basis of previous studies (22) .
Oxidative Fluorescent Microtopography
The generation of superoxide was observed with dihydroethidium (DHE) fluorescence as described previously (23) .
Cells cultured on glass slides were incubated in PBS containing DHE (2 × 10 − 6 mol/l) at 37°C for 30 min in a dark, humidified chamber. DHE is oxidized on the reaction with superoxide to ethidium bromide, which binds to DNA in the nucleus and fluoresces red. Images were obtained with a BioRad MRC-1024 laser scanning confocal microscope, and fluorescence was detected with a 590-nm long-pass filter.
Protein Extraction and Western Blotting
Cells were lysed in ice-cold lysis buffer of the following composition: 50 mmol/l Tris, 150 mmol/l NaCl, 1% Triton X-100, and 50 mmol/l NaF, pH 7.5. Total protein levels were determined by the bicinchoninic acid (BCA) method (Pierce, Rockford, USA). Immunoblotting was performed according to a standard protocol. Proteins were mixed with sample buffer containing β-mercaptoethanol and were heated at 100°C for 5 min. The protein extracts were then separated with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by 7.5% acrylamide gel. The samples were then electrotransferred to polyviniliden difluoride (PVDF) membranes and blocked overnight with 4% nonfat dry milk in PBS with 0.1% Tween 20 at room temperature. The membranes were incubated with mouse monoclonal antibody against p47 phox (1:2,500; BD Biosciences, Franklin Lakes, USA) overnight and then were incubated for 1 h with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (1:2,500, anti-mouse IgG (H+L) HRP conjugate; Promega Corp., Madison, USA). The detection of chemiluminescence was carried out with enhanced chemiluminescence (ECL; Amersham Biosciences Corp., Piscataway, USA). The bands were quantified by scanning densitometry, and the amount of each product was normalized with respect to the amount of the bands of actin (1:5,000, mouse anti-actin monoclonal antibody; Chemicon International, Temecula, USA; 1:2,500, Promega Corp.).
RNA Isolation and Reverse Transcription (RT)-Polymerase Chain Reaction (PCR)
The total RNAs were isolated from cells by the acid guanidium thiocyanate-phenol-chloroform method using Isogen reagent (Nippon Gene, Tokyo, Japan) and were subsequently treated with RNase-free DNase. The RNA concentration was determined by ultraviolet (UV) light absorbance at 260 nm. For the RT-PCR analysis, first-strand cDNA was synthesized from total RNA (1 μg) with a commercially available RT kit (SuperScript™ First-Strand Synthesis System for RT-PCR; Invitrogen Co., Carlsbad, USA) using an Oligo(dT)12-18 primer. Table 1 shows the primer sequences used to amplify cDNA fragments by PCR using Taq DNA polymerase (TaKaRa Ex Taq™; Takara Bio Inc., Kyoto, Japan). Database searches of GenBank were performed with BLASTN. The PCR cycles were performed in a thermal cycler (iCycler; BioRad Laboratories, Inc., Hercules, USA) with the following profile after a denaturing period of 5 min at 94°C: denaturation, 30 s at 94°C; annealing, 40 s at optimum temperature (shown in Table 1 ); and a 1-min extension step at 72°C. The last cycle was followed by a final extension step of 5 min at 72°C. For quantitation, preliminary studies were performed to determine the optimum annealing temperature and a linear correlation between the PCR cycles and the densitometry intensity of the PCR products was confirmed (data not shown). Genomic DNA contamination was checked by subjecting samples to the PCR procedure without adding reverse transcriptase. The PCR products thus obtained were separated 
Results
Superoxide Generation
Incubation of rat aortic endothelial cells with Ang II caused an increase in the generation of superoxide, which reached its maximum after 3 h (Fig. 1) . Therefore, in all subsequent experiments, cells were incubated with Ang II for 3 h. Pretreatment with amlodipine and manidipine markedly decreased the generation of superoxide. Amlodipine or manidipine alone had no effect on the basal levels of superoxide formation (Fig. 2) .
Expression of Protein for NADPH Oxidase
As shown in Fig. 3 , the endothelial expression of p47 phox protein was significantly increased by a 3-h period of stimulation with Ang II. Pretreatment with amlodipine or manidipine prevented the Ang II-induced increase in the expression of p47 phox protein.
Expression of mRNA for Heme Oxygenase-1 (HO-1)
Ang II induced a significant increase in the expression of HO-1 mRNA in endothelial cells. Pretreatment with amlodipine caused a further increase in the expression of HO-1, whereas pretreatment with manidipine suppressed the overexpression of HO-1 mRNA induced by Ang II. Amlodipine or manidipine alone had no effect on the basal expression of HO-1 mRNA (Fig. 4) . 
Expression of mRNAs for Adhesion Molecules
Treatment with Ang II resulted in higher levels of expression of vascular cell adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1) mRNA, as compared with those in non-treated cells. Treatment with amlodipine or manidipine did not affect the basal expression of mRNA for these adhesion molecules (Fig. 6 ).
Expression of mRNA for LOX-1
Incubation with Ang II significantly increased the expression of LOX-1 mRNA. This Ang II-induced increase in LOX-1 mRNA level was restored to the control level by pretreatment with either amlodipine or manidipine. Amlodipine or manidipine alone had no effect on the basal expression of LOX-1 mRNA (Fig. 7) .
Discussion
The present study demonstrated that dihydropyridine calcium channel blockers such as amlodipine and manidipine restored increased superoxide production and NADPH oxidase expression and attenuated the overexpression of mRNA associated with inflammation in Ang II-stimulated rat aortic endothelial cells. Interestingly, these antioxidant and antiinflammatory effects of calcium channel blockers were mediated by inhibition of the expression of LOX-1. In this study, we were able to demonstrate that the beneficial effects of cal- cium channel blockers were independent of the effects of these agents via calcium channels, because macrovascular endothelial cells have been reported to lack voltage-operated L-type calcium channels (24, 25) . In general, oxidative stress induces endothelial dysfunction and increases subsequent vascular remodeling in patients with atherosclerosis (26) . In order to determine the molecular source of endothelial superoxide, we investigated the expression of the NADPH oxidase subunit; we found that the expression of the NADPH oxidase subunit p47 phox showed a significant correlation with the generation of superoxide in Ang II-treated rat aortic endothelial cells. Indeed, Zhang et al. demonstrated that Ang II induced a release of superoxide in endothelial cells via activation of NADPH oxidase (27) . More importantly, we also demonstrated that either of two calcium channel blockades, amlodipine or manidipine, effectively suppressed this type of increase in superoxide generation and the expression of NADPH oxidase, suggesting that these agents acted as antioxidants by downregulating NADPH oxidase expression. It has been reported that Ang II increases HO-1 expression in hypertensive rats, suggesting a possible tissue protective effect of HO-1 in response to Ang II-induced tissue injury (14) . An Ang II-induced increase in the expression of the HO-1 gene was also seen in our study; this type of increase was further enhanced by coincubation with amlodipine, but not by coincubation with manidipine. It has been reported that amlodipine exerts its antioxidant effects by the preservation of superoxide dismutase (SOD) (28). Our results, taken together with the findings of the previous reports, indicate that amlodipine may prevent oxidative stress not only by blocking the production of superoxide, but also by stimulating superoxide-quenching activity. On the other hand, it is likely that manidipine exerts its antioxidant effects by blocking the main source of oxidative stress, without affecting the antioxidant enzymes. However, another study using monocytes suggested that the preservation of HO-1 might be a mechanism of the antioxidant effects of manidipine (29) . Further examination will be necessary to clarify this mechanism.
Oxidative stress is considered to participate in the develop- (30, 31) . Upregulation of adhesion molecules and MCP-1 occurs at sites of lesion formation in the endothelial cells in early atherosclerosis (32) . Ang II has been shown to enhance the expression of VCAM-1, ICAM-1, and MCP-1 in vascular endothelial cells (1) . Consistent with these reports, we demonstrated that the mRNA levels of these inflammatory molecules were increased in Ang II-treated rat aortic endothelial cells; moreover, an important result of the present study was that calcium channel blockers prevented the overexpression of these molecules. In addition, it has been reported that calcium channel blockers suppress the overexpressions of these molecules both in vivo (33, 34) and in vitro (18) . Our results, taken together with the findings of the previous reports, indicate that calcium channel blockers may prevent endothelial inflammation, the mechanism of which has been received a great deal of attention as a central factor in the development of atherosclerosis and associated complications.
LOX-1, a receptor for OxLDL, plays a critical role in endothelial dysfunction and atherosclerosis (7). Ang II has been shown to increase the expression of LOX-1 in the endothelium (7). Based on studies by Nagase et al., it has been suggested that oxidative stress is involved in Ang II-mediated upregulation of the expression of LOX-1 (35) . Furthermore, activation of LOX-1 may cause an additional increase in superoxide production, resulting in a vicious cycle in which the increased expression of LOX-1 further increases oxidative stress in Ang II-treated rat aortic endothelial cells. In addition, it has been demonstrated that activation of LOX-1 causes upregulation of the expression of adhesion molecules (7) . In the present study, we found for the first time that treatment with calcium channel blockers prevented the Ang IIinduced increase in the levels of LOX-1 mRNA in rat aortic endothelial cells in vitro. Along these lines, Zhou et al. demonstrated that amlodipine prevented an increase in the expres- sion of LOX-1 mRNA, in addition to suppressing the production of superoxide in Ang II-infused rat aortae in vivo (36) . Previous reports have compelling supported the notion that the beneficial effects of calcium channel blockers observed in Ang II-treated rat aortic endothelial cells may have been mediated at least in part by their effects on LOX-1. We preliminarily found that the effect of calcium channel blockers on superoxide production was attenuated in the presence of an NADPH oxidase inhibitor, apocynin (data not shown). Because it has been reported that LOX-1-induced superoxide production may be related to the increased activity of NADPH oxidase (37), we suggest that the antioxidative and anti-inflammatory effects of calcium channel blockers might be due to the inhibition of LOX-1 expression.
In conclusion, we here demonstrated the direct antioxidative and anti-inflammatory effects of calcium channel blockers in Ang II-treated cultured rat aortic endothelial cells, including the inhibition of LOX-1 expression. Such vasoprotective effects of calcium channel blockers are not likely to be mediated by their effects via calcium channels, which vascular endothelial cells have been reported to lack. The present study might therefore provide novel insights into the protection conferred by calcium channel blockers against cardiovascular events.
